Not checkedNot checked for notices yet.
Clinically-relevant postzygotic mosaicism in parents and children with developmental disorders in trio exome sequencing data
C. F. Wright, E. Prigmore, D. Rajan and 7 more
Nature Communications · 2019
doi:10.1038/s41467-019-11059-2 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Mosaic genetic variants can have major clinical impact. We systematically analyse trio exome sequence data from 4,293 probands from the DDD Study with severe developmental disorders for pathogenic postzygotic mosaicism (PZM) in the child or a clinically-unaffected parent, and use ultrahigh-depth sequencing to validate candidate mosaic variants. We observe that levels of mosaicism for small genetic variants are usually equivalent in both saliva and blood and ~3% of causative de novo mutations exhibit PZM; this is an important observation, as the sibling recurrence risk is extremely low. We identify parental PZM in 21 trios (0.5% of trios), resulting in a substantially increased sibling recurrence risk in future pregnancies. Together, these forms of mosaicism account for 40 (1%) diagnoses in our cohort. Likely child-PZM mutations occur equally on both parental haplotypes, and the penetrance of detectable mosaic pathogenic variants overall is likely to be less than half that of constitutive variants.
Abstract licence: CC BY-NC-ND
References63
- 21.
- 25.
- 33.
- 35.
- 37.
- 39.
34 more references, whose wording the paper’s licence keeps private.
All 63 referencesCited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.